V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16626964 | 330006807 | ERA20 | 8 | X721 | 1 | 2018-03-10 | NOT CHEMO | 330005070 | 330010301 | 330006808 |
| 16626965 | 330006807 | EUH | 8 | null | 1 | 2018-03-10 | NOT CHEMO | 330005070 | 330010301 | 330006808 |
| 16626966 | 330006807 | ELW | 8000 | X721 | 1 | 2018-03-10 | FLUOROURACIL | 330005070 | 330010301 | 330006808 |
| 16626967 | 330006807 | EEI00 | 5650 | null | 1 | 2018-03-10 | FLUOROURACIL | 330005070 | 330010301 | 330006808 |
| 16626968 | 330006808 | EEI00 | 0 | null | 1 | 2015-12-18 | VINCRISTINE | 330005086 | 330013238 | 330006809 |
| 16626969 | 330006808 | EPH | 2880 | X721 | 1 | 2015-12-18 | FLUOROURACIL | 330005086 | 330013238 | 330006809 |
| 16626970 | 330006809 | Haqrsvarq | 150 | X729 | 1 | 2014-06-16 | CETUXIMAB | 330005089 | 330003561 | 330006810 |
| 16626971 | 330006810 | EEI00 | 178 | N/A | 1 | 2015-03-06 | AVELUMAB | 330005089 | 330003562 | 330006811 |
| 16626972 | 330006811 | ED301 | 2 | X729 | 1 | 2014-01-31 | ETOPOSIDE | 330005090 | 330003563 | 330006812 |
| 16626973 | 330006811 | EK1EN | 110 | null | 2 | 2014-02-07 | NOT CHEMO | 330005090 | 330003563 | 330006812 |
| 16626974 | 330006811 | E0N03 | 814.5 | null | 1 | 2014-02-08 | TRIAL | 330005090 | 330003563 | 330006812 |
| 16626975 | 330006811 | EJRNN | 3200 | null | 1 | 2014-02-09 | PACLITAXEL | 330005090 | 330003563 | 330006812 |
| 16626976 | 330006811 | EEI00 | 5600 | X724 | 1 | 2014-02-09 | IPILIMUMAB | 330005090 | 330003563 | 330006812 |
| 16626977 | 330006812 | ECL01 | 2000 | X721 | 2 | 2016-11-07 | ETOPOSIDE | 330005103 | 330003567 | 330006813 |
| 16626978 | 330006812 | EEI00 | 1.48 | X724 | 1 | 2016-11-07 | CETUXIMAB | 330005103 | 330003567 | 330006813 |
| 16626979 | 330006812 | EEI00 | 100 | X724 | 1 | 2016-11-07 | CYTARABINE | 330005103 | 330003567 | 330006813 |
| 16626980 | 330006812 | EEI00 | 3600 | X721 | 9 | 2016-11-07 | METHOTREXATE | 330005103 | 330003567 | 330006813 |
| 16626981 | 330006812 | EJR | 2320 | X729 | 1 | 2016-11-19 | NIVOLUMAB | 330005103 | 330003567 | 330006813 |
| 16626982 | 330006812 | EGU02 | 0 | X724 | 1 | 2016-11-19 | VINCRISTINE | 330005103 | 330003567 | 330006813 |
| 16626983 | 330006812 | ERA20 | 160 | X721 | 1 | 2016-11-20 | DOCETAXEL | 330005103 | 330003567 | 330006813 |
| 16626984 | 330006812 | ERS12 | 1600 | X721 | 1 | 2016-11-20 | FLUOROURACIL | 330005103 | 330003567 | 330006813 |
| 16626985 | 330006812 | EOI | 140 | X729 | 1 | 2016-11-21 | CISPLATIN | 330005103 | 330003567 | 330006813 |
| 16626986 | 330006813 | EEI00 | 2 | null | 1 | 2016-12-29 | CYCLOPHOSPHAMIDE | 330005105 | 330007916 | 330006814 |
| 16626987 | 330006814 | ED301 | 2 | null | 1 | 2017-09-20 | IFOSFAMIDE | 330005108 | 330010303 | 330006815 |
| 16626988 | 330006814 | EJR | 300 | null | 1 | 2017-09-20 | NOT CHEMO | 330005108 | 330010303 | 330006815 |
| 16626989 | 330006814 | EUZ | 1.5 | null | 1 | 2017-09-20 | NOT CHEMO | 330005108 | 330010303 | 330006815 |
| 16626990 | 330006816 | EEI00 | 560 | null | 1 | 2016-02-29 | ETOPOSIDE | 330005132 | 330003569 | 330006817 |
| 16626991 | 330006816 | ECL01 | 3840 | X724 | 1 | 2016-02-29 | ETOPOSIDE | 330005132 | 330003569 | 330006817 |
| 16626992 | 330006816 | EEI00 | 1800 | null | 2 | 2016-02-29 | NIVOLUMAB | 330005132 | 330003569 | 330006817 |
| 16626993 | 330006816 | EEI00 | 55 | X724 | 1 | 2016-02-29 | TOPOTECAN | 330005132 | 330003569 | 330006817 |
| 16626994 | 330006816 | EZ102 | 2560 | X724 | 1 | 2016-02-29 | METHOTREXATE | 330005132 | 330003569 | 330006817 |
| 16626995 | 330006816 | ED301 | 0 | N/A | 1 | 2016-02-29 | DOXORUBICIN | 330005132 | 330003569 | 330006817 |
| 16626996 | 330006816 | EGQ01 | 1400 | X721 | 1 | 2016-02-29 | FLUOROURACIL | 330005132 | 330003569 | 330006817 |
| 16626997 | 330006816 | EN201 | 2000 | null | 1 | 2016-03-01 | FLUOROURACIL | 330005132 | 330003569 | 330006817 |
| 16626998 | 330006816 | EXO | 160 | X722 | 1 | 2016-03-01 | CISPLATIN | 330005132 | 330003569 | 330006817 |
| 16626999 | 330006818 | EK1EN | 40 | X721 | 1 | 2017-06-18 | ETOPOSIDE | 330005132 | 330003569 | 330006819 |
| 16627000 | 330006818 | EE813 | 3600 | null | 1 | 2017-06-19 | ETOPOSIDE | 330005132 | 330003569 | 330006819 |
| 16627001 | 330006818 | EE813 | 150 | x724 | 5 | 2017-06-19 | IFOSFAMIDE | 330005132 | 330003569 | 330006819 |
| 16627002 | 330006818 | EEI00 | 3800 | X729 | 1 | 2017-06-19 | TOPOTECAN | 330005132 | 330003569 | 330006819 |
| 16627003 | 330006818 | EEI00 | 1800 | X724 | 1 | 2017-06-19 | STEROID | 330005132 | 330003569 | 330006819 |
| 16627004 | 330006818 | EE813 | 5200 | x724 | null | 2017-06-20 | ETOPOSIDE | 330005132 | 330003569 | 330006819 |
| 16627005 | 330006818 | ENW | 1500 | X721 | 1 | 2017-06-20 | FLUOROURACIL | 330005132 | 330003569 | 330006819 |
| 16627006 | 330006818 | ERA20 | 2000 | X724 | 1 | 2017-06-20 | FLUOROURACIL | 330005132 | 330003569 | 330006819 |
| 16627007 | 330006818 | EKJ | 300 | X721 | null | 2017-06-20 | NOT CHEMO | 330005132 | 330003569 | 330006819 |
| 16627008 | 330006818 | EGU02 | 6400 | X724 | 1 | 2017-06-20 | FLUOROURACIL | 330005132 | 330003569 | 330006819 |
| 16627009 | 330006818 | EOQ01 | 700 | 722 | 1 | 2017-06-21 | RITUXIMAB | 330005132 | 330003569 | 330006819 |
| 16627010 | 330006819 | EC4 | 27 | null | 1 | 2015-03-01 | NOT CHEMO | 330005140 | 330003571 | 330006820 |
| 16627011 | 330006819 | EUZ | 1200 | X721 | 9 | 2015-03-02 | IFOSFAMIDE | 330005140 | 330003571 | 330006820 |
| 16627012 | 330006819 | EJR | 2880 | X728 | 2 | 2015-03-09 | NOT MATCHED | 330005140 | 330003571 | 330006820 |
| 16627020 | 330006825 | EEI00 | 180 | null | 1 | 2015-01-15 | NOT CHEMO | 330005173 | 330007920 | 330006826 |